Mid-cap Picks with Anil Singhvi: Hemang Jani picks Canfin Homes, Granules India and AU Small Finance Bank for good returns
In Thursday's episode of Special Mid-Cap Stocks, market expert Hemang Jani recommended three more mid-cap stocks with long term, positional medium term and short-term views. These stocks have the potential to get big gains for the investors, he told Zee Business Managing Editor Anil Singhvi. Know what is working for Canfin Homes, Granules India and AU Small Finance Bank stocks here.
In Thursday's episode of Special Mid-Cap Stocks, market expert Hemang Jani recommended three more mid-cap stocks with long term, positional medium term and short-term views. These stocks have the potential to get big gains for the investors, he told Zee Business Managing Editor Anil Singhvi. Know what is working for Canfin Homes, Granules India and AU Small Finance Bank stocks here.
Long Term Pick: Canfin Homes
This is a small company in the housing finance segment and caters lower and middle class income people. Markets have seen huge turbulence in the housing finance sector in the past 2 to 3 years. He said that companies which survived this tough phase, next 2 to 3 years will be extremely good for them. Affordable housing segment will focus on lower and middle income earners; the risk is relatively low due when compared to higher loan amounts. Also, the growth potential will be more for this company when compared to other large companies. Revival in the sentiment of PSU Banks, will benefit this company as Canara Bank is the parent company of Canfin Homes. The stock is extremely attractively priced. The target price on Canfin Homes stock is Rs 650.
See Zee Business Live TV Streaming Below:
Positional Term Pick: Granules India
Granules India stock is from midcap pharma space. Granules India is doing well and is a large-scale vertically integrated company manufacturing Active Pharmaceutical Ingredient (API) Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD). The earnings growth of Granules India has been extremely good. The stock price has fallen off its highs in the past 1 to 2 months. Overall, he is seeing growth of 33% in Granules India till 2023. Granules India receives USFDA approval for Acetaminophen, Aspirin and Caffeine Tablets. The price target on Granules India stock is Rs 460.
शॉर्ट टर्म हो या पोजीशनल या लॉन्ग टर्म...इन मिडकैप शेयरों में मिलेगा रिटर्न दमदार
हेमांग जानी से जानिए दमदार फंडामेंटल वाली उनकी 3 बेहतरीन SPL मिडकैप PICKS #SPLMidcapStocks @AnilSinghvi_ @hemangjani9 pic.twitter.com/NuHB26kYzE
— Zee Business (@ZeeBusiness) February 25, 2021
Short Term Pick: AU Small Finance Bank
Momentum in 2-tier and 3-tier Banks has been good over the past few months, investors are more interested in buying such Banks and earnings have also been strong for these Banks. Collection Efficiency of the Bank has been better and other parameters of the banks performance has been good. Granules India stock has been included in Nifty Bank which is a huge positive for the Bank. Granules India stock could see buying of Rs 500 cr approximately. Granules India stock can move up 12 to 15% from the current market price of Rs 1180.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Top 7 Gold ETFs With Best Returns in 3 Years: No.1 ETF has converted Rs 7 lakh investment into Rs 10.80 lakh; know how others have fared
Top 7 Flexi Cap Mutual Funds With up to 52% SIP Return in 1 Year: Rs 20,000 monthly SIP investment in No. 1 fund has generated Rs 3.02 lakh; know about others too
08:09 AM IST